Moreover, semaglutide is evolving past just diabetes and weight loss, thus expanding into treatments for heart failure, chronic kidney disease, and metabolic dysfunction
This anomaly may arise from confounding factors such as metformin exposure or consumption of polyphenol-rich green tea, though mechanistic validation is pending ( Butyrivibrio , Bifidobacterium bifidum , Megasphaera , Prevotella , Escherichia coli ), which may obscure true microbiota-disease relationships ( 3 Impacts of gut microbiota dysbiosis on gastrointestinal nerves and function In the diabetic state, gut microbiota dysbiosis further exacerbates GI motility dysfunction and impairs the ENS
This led Pfizer to focus on the development of a once-daily version of the drug, which showed early success in Phase I trials (NCT06567327 and NCT06568731)
Second, we evaluated GLP-1RAs as a class, comparing them with other anti-diabetic medication classes, without assessing individual GLP-1RAs, primarily due to limited sample sizes